Advanced Search


Study ID Status Title Patient Level Data
GLP110125 Completed A 16-Week, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Doses and Multiple Treatment Regimens of GSK716155, with Byetta as an Open Label Active Reference, in Subjects with Type 2 Diabetes Mellitus Study Listed on
GM2006/00037/00 Completed A Phase II Multicentre, Randomised, Double-Blind, Placebo and Active-Controlled, Dose-Ranging, Parallel Group Study of the Safety and Efficacy of a New Chemical Entity When Administered at daily doses of 50 mg, 100 mg, and 150 mg Oral Tablets in Combination with Ondansetron Hydrochloride and Dex ...
GPK:89:06 Completed To Investigate the Pharmacokinetics of Hydroxynaphthoic Acid in Healthy Volunteers
GPK:89:08 Completed Comparison of the Single-Dose Pharmacokinetics of Hydroxynaphthoic Acid in Subjects with Renal Failure and in Healthy Subjects.
GT1109727 Completed Single-Blind, randomised, placebo-controlled first time in human study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of single oral escalating doses of GSK1018921 in healty volunteers and a randomized, double-blind, double dummy, placebo controlled, three-way crossover study in a separate cohort of healthy volunteers to test the effect of single doses of GSK1018921 and nicotine on qEEG and MMN in healthy volunteers
GTH001/92 Completed Comparison of ondansetron and placebo for preventing postoperative nausea and emesis in gastrointestinal tract surgery: a multicenter randomised controlled trial. –Extensive searching has revealed that no clinical study report is available for this study.
GTH001/94 Completed An evaluator-blind, randomised, within-patient comparison of ondansetron given three times daily vs. twice daily with or without dexamathasone vs. metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting in children.
H34/064/V/87 (UK64) Completed The Pharmacokinetics and Bioequivalence of, and Effect of Food on, Lamotrigine Capsules and Tablets
H34/100/V/88 Completed The bioequivalence of lamotrigine tablets and syrup
H34/107-STW881 Completed The pharmacokinetics of lamotrigine in chronic renal failure: Influence of haemodialysis
H34/V/AFC/84/01 Completed Pharmacokinetics of Lamotrigine After Oral and Intravenous Infusion Administration in Normal Volunteers
H34-035-C86 Completed A Multicentre Randomised Double-Blind Placebo Controlled Crossover Trial of Lamotrigine (LTG) as Add-On Therapy in Treatment-Resistant Epilepsy: Australia
H34-049-C87/H34-089-C88 Completed A Multicentre, Double Blind Comparison of the Efficacy and Safety of Lamotrigine and Carbamazepine Monotherapy in Patients with Newly Diagnosed Epilepsy
H34-074-C87 Completed A multicenter, double-blind comparison of the efficacy and safety of lamotrigine and phenytoin monotherapy in patients with newly diagnosed epilepsy.
H3A106104 Terminated An Open Label, Dose Escalation Study With A Double Blind Randomised Placebo Controlled Withdrawal To Examine The Effects Of The Histamine H3 Antagonist GSK189254 In Patients With Narcolepsy.
H3A106308 Completed A double-blind, double-dummy, placebo-controlled, incomplete block, two period crossover study of the histamine H3 antagonist GSK189254 and duloxetine in the electrical hyperalgesia model of central sensitisation in healthy volunteers
H3B109689 Completed A single blind, placebo-controlled, randomised study in mild to moderate Alzheimer’s disease patients to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK239512, a selective histamine H3 receptor antagonist Study Listed on
H73-020-V Completed The Effects of Probenecid and Cimetidine on the Pharmacokinetics of Valaciclovir and its Metabolite Acyclovir in Healthy Male Volunteers
HAZ30001 Completed A prospective, randomised, open-label, blinded-endpoint, parallel group study comparing telmisartan plus hydrochlorothiazide with losartan plus hydrochlorothiazide in subjects with essential hypertension.
HAZ30002 Completed A prospective, randomised, open-label, parallel group study to investigate the effects of 12 months treatment with telmisartan plus hydrochlorothiazide or ramipril plus hydrochlorothiazide on left ventricular mass index in subjects with left ventricular hypertrophy and essential hypertension
HGC10007 Completed A randomised, placebo controlled, parallel group pilot study in patients with allergic rhinitis due to house dust mite to determine i) the effectiveness of 7 days treatment with fluticasone propionate 200 m/day, upon nasal clinical response and nasal biopsy after intranasal allergen challenge…
HGC10008 Completed A randomised, double-blind, double-dummy, placebo-controlled, three-way crossover study in patients with allergic rhinitis due to house dust mite to compare the effect versus placebo of 7 days treatment with a new chemical entity (NCE) administered…
HGS1021-C1063 Completed A randomized, single-blind, placebo-controlled study to evaluate the safety and tolerability of raxibacumab (human monoclonal antibody to B. anthracis protective antigen) in healthy subjects Study Listed on
HGS1021-C1069 Completed An Open-Label Study to Evaluate the Immunogenicity and Safety of Raxibacumab (Human Monoclonal Antibody to B. anthracis Protective Antigen) Administered in Healthy Subjects Study Listed on
HH3104994 Completed A randomised, double blind, placebo controlled, two way crossover, three phase study to investigate the trial models; Vienna Challenge Chamber, in and out of season and Park study in season and the clinical efficacy of repeat doses of fluticasone propionate in subjects with seasonal allergic rhinitis (SAR).



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.